Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christopher A Hinze"'
Autor:
Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, Christopher A. Hinze, Nora Drick, Nikolaus Kneidinger, Jürgen Behr, Christian Taube, Tobias Welte, Ina Haasler, Katrin Milger
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologics in this context. W
Externí odkaz:
https://doaj.org/article/9b65f82e70434ca195edfb5cf288a4e3
Autor:
Pia Maria Plank, Christopher Alexander Hinze, Ludwig Sedlacek, Tobias Welte, Hendrik Suhling, Jens Gottlieb
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 32, Iss , Pp 100380- (2023)
Externí odkaz:
https://doaj.org/article/d42d4a318ad44713b08ca170a7792a51
Autor:
Pia Maria Plank, Christopher Alexander Hinze, Victoria Campbell, Stefanie Konwert, Tobias Welte, Nora Drick, Moritz Z Kayser, Hendrik Suhling, Jan Fuge
Publikováno v:
Journal of Asthma and Allergy. 16:421-431
Pia Maria Plank,1,* Christopher Alexander Hinze,2,* Victoria Campbell,3 Stefanie Konwert,4 Tobias Welte,1,4 Nora Drick,1 Moritz Z Kayser,1 Hendrik Suhling,1,4,* Jan Fuge1,4,* 1Department of Cardiology and Angiology, Hannover Medical S
Publikováno v:
Am J Transplant
Allogeneic lung transplantation (LuTx) is considered the treatment of choice for a broad range of advanced, progressive lung diseases resistant to conventional treatment regimens. Ischemia reperfusion injury (IRI) occurring upon reperfusion of the ex
Autor:
Marie Moog, Lars Knudsen, Christopher A. Hinze, Ulrich A. Maus, David S. DeLuca, Tobias Welte, Martin Kolb
Publikováno v:
Rare ILD / DPLD.
Autor:
Martin Kolb, David S. DeLuca, Tobias Welte, Christopher A. Hinze, Marie Moog, Ulrich A. Maus, Regina Maus
Publikováno v:
Rare ILD / DPLD.